Loading…
Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin
Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressi...
Saved in:
Published in: | International journal of nanomedicine 2017-01, Vol.12, p.3433-3446 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123 |
---|---|
cites | |
container_end_page | 3446 |
container_issue | |
container_start_page | 3433 |
container_title | International journal of nanomedicine |
container_volume | 12 |
creator | Kameyama, Kazuhisa Motoyama, Keiichi Tanaka, Nao Yamashita, Yuki Higashi, Taishi Arima, Hidetoshi |
description | Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c
mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function. |
doi_str_mv | 10.2147/IJN.S133482 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8</doaj_id><sourcerecordid>1899106735</sourcerecordid><originalsourceid>FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</originalsourceid><addsrcrecordid>eNpdkk1v1DAQhiMEoqVw4o4icUGqUvwRf12QqorCogoOwBXLdsa7XiXx4jiF_C1-CL8Jl12qltNYM48ejcZvVT3H6IzgVrxeffh49hlT2kryoDrGWMiGIEwf3nkfVU-maYsQE5Krx9URka3ilKDj6ttq7GaXQxzr6Osh5LjbmPXSDNAFk6GrzZhDnoeYalOw65CX-kfIm9rHvswbs9vB2BVugLxZ-ub3r8Ytro8d_MwpjE-rR970Ezw71JPq6-XbLxfvm6tP71YX51eNawXLjZGEKMatNAQDRx0QB4oz74UhBFspgHsqCUJCKgaGgrfIWeKJBGAWE3pSrfbeLpqt3qUwmLToaIL-24hprU3KwfWgeQdU8NYq1rWts2Bbi8Eg74tLciOL683etZttOYODMSfT35Pen4xho9fxWrMWC85vBK8OghS_zzBlPYTJQd-bEeI8aSyVwogLygr68j90G-c0llNpQqjCTDKFC3W6p1yK05TA3y6Dkb7JgC4Z0IcMFPrF3f1v2X-fTv8AOuivyw</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2239158591</pqid></control><display><type>article</type><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><source>Publicly Available Content (ProQuest)</source><source>Taylor & Francis Open Access Journals</source><source>PubMed Central</source><creator>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</creator><creatorcontrib>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</creatorcontrib><description>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c
mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</description><identifier>ISSN: 1178-2013</identifier><identifier>ISSN: 1176-9114</identifier><identifier>EISSN: 1178-2013</identifier><identifier>DOI: 10.2147/IJN.S133482</identifier><identifier>PMID: 28496320</identifier><language>eng</language><publisher>New Zealand: Taylor & Francis Ltd</publisher><subject>Adenosine triphosphate ; Angiogenesis ; Animals ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Apoptosis ; Autophagy ; Autophagy - drug effects ; beta-Cyclodextrins - chemistry ; beta-Cyclodextrins - pharmacology ; Cancer ; Cell Survival - drug effects ; Cervical cancer ; Clinical trials ; folate receptor ; Folate Receptor 1 - metabolism ; Folic Acid - chemistry ; Folic Acid - pharmacology ; Graduate studies ; Humans ; KB Cells - drug effects ; Kinases ; Life sciences ; Male ; methyl--cyclodextrin ; Mice ; Mice, Inbred BALB C ; Mitochondria ; Mitochondrial Degradation - drug effects ; mitophagy ; Molecular Targeted Therapy - methods ; Original Research ; Protein Kinases - metabolism ; Reactive oxygen species ; tumor targeting ; Tumors ; Vitamin B ; Xenograft Model Antitumor Assays</subject><ispartof>International journal of nanomedicine, 2017-01, Vol.12, p.3433-3446</ispartof><rights>2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2017 Kameyama et al. This work is published and licensed by Dove Medical Press Limited 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2239158591/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2239158591?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,74998</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28496320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kameyama, Kazuhisa</creatorcontrib><creatorcontrib>Motoyama, Keiichi</creatorcontrib><creatorcontrib>Tanaka, Nao</creatorcontrib><creatorcontrib>Yamashita, Yuki</creatorcontrib><creatorcontrib>Higashi, Taishi</creatorcontrib><creatorcontrib>Arima, Hidetoshi</creatorcontrib><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><title>International journal of nanomedicine</title><addtitle>Int J Nanomedicine</addtitle><description>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c
mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</description><subject>Adenosine triphosphate</subject><subject>Angiogenesis</subject><subject>Animals</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Autophagy</subject><subject>Autophagy - drug effects</subject><subject>beta-Cyclodextrins - chemistry</subject><subject>beta-Cyclodextrins - pharmacology</subject><subject>Cancer</subject><subject>Cell Survival - drug effects</subject><subject>Cervical cancer</subject><subject>Clinical trials</subject><subject>folate receptor</subject><subject>Folate Receptor 1 - metabolism</subject><subject>Folic Acid - chemistry</subject><subject>Folic Acid - pharmacology</subject><subject>Graduate studies</subject><subject>Humans</subject><subject>KB Cells - drug effects</subject><subject>Kinases</subject><subject>Life sciences</subject><subject>Male</subject><subject>methyl--cyclodextrin</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Mitochondria</subject><subject>Mitochondrial Degradation - drug effects</subject><subject>mitophagy</subject><subject>Molecular Targeted Therapy - methods</subject><subject>Original Research</subject><subject>Protein Kinases - metabolism</subject><subject>Reactive oxygen species</subject><subject>tumor targeting</subject><subject>Tumors</subject><subject>Vitamin B</subject><subject>Xenograft Model Antitumor Assays</subject><issn>1178-2013</issn><issn>1176-9114</issn><issn>1178-2013</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNpdkk1v1DAQhiMEoqVw4o4icUGqUvwRf12QqorCogoOwBXLdsa7XiXx4jiF_C1-CL8Jl12qltNYM48ejcZvVT3H6IzgVrxeffh49hlT2kryoDrGWMiGIEwf3nkfVU-maYsQE5Krx9URka3ilKDj6ttq7GaXQxzr6Osh5LjbmPXSDNAFk6GrzZhDnoeYalOw65CX-kfIm9rHvswbs9vB2BVugLxZ-ub3r8Ytro8d_MwpjE-rR970Ezw71JPq6-XbLxfvm6tP71YX51eNawXLjZGEKMatNAQDRx0QB4oz74UhBFspgHsqCUJCKgaGgrfIWeKJBGAWE3pSrfbeLpqt3qUwmLToaIL-24hprU3KwfWgeQdU8NYq1rWts2Bbi8Eg74tLciOL683etZttOYODMSfT35Pen4xho9fxWrMWC85vBK8OghS_zzBlPYTJQd-bEeI8aSyVwogLygr68j90G-c0llNpQqjCTDKFC3W6p1yK05TA3y6Dkb7JgC4Z0IcMFPrF3f1v2X-fTv8AOuivyw</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Kameyama, Kazuhisa</creator><creator>Motoyama, Keiichi</creator><creator>Tanaka, Nao</creator><creator>Yamashita, Yuki</creator><creator>Higashi, Taishi</creator><creator>Arima, Hidetoshi</creator><general>Taylor & Francis Ltd</general><general>Dove Medical Press</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170101</creationdate><title>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</title><author>Kameyama, Kazuhisa ; Motoyama, Keiichi ; Tanaka, Nao ; Yamashita, Yuki ; Higashi, Taishi ; Arima, Hidetoshi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adenosine triphosphate</topic><topic>Angiogenesis</topic><topic>Animals</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Autophagy</topic><topic>Autophagy - drug effects</topic><topic>beta-Cyclodextrins - chemistry</topic><topic>beta-Cyclodextrins - pharmacology</topic><topic>Cancer</topic><topic>Cell Survival - drug effects</topic><topic>Cervical cancer</topic><topic>Clinical trials</topic><topic>folate receptor</topic><topic>Folate Receptor 1 - metabolism</topic><topic>Folic Acid - chemistry</topic><topic>Folic Acid - pharmacology</topic><topic>Graduate studies</topic><topic>Humans</topic><topic>KB Cells - drug effects</topic><topic>Kinases</topic><topic>Life sciences</topic><topic>Male</topic><topic>methyl--cyclodextrin</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Mitochondria</topic><topic>Mitochondrial Degradation - drug effects</topic><topic>mitophagy</topic><topic>Molecular Targeted Therapy - methods</topic><topic>Original Research</topic><topic>Protein Kinases - metabolism</topic><topic>Reactive oxygen species</topic><topic>tumor targeting</topic><topic>Tumors</topic><topic>Vitamin B</topic><topic>Xenograft Model Antitumor Assays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kameyama, Kazuhisa</creatorcontrib><creatorcontrib>Motoyama, Keiichi</creatorcontrib><creatorcontrib>Tanaka, Nao</creatorcontrib><creatorcontrib>Yamashita, Yuki</creatorcontrib><creatorcontrib>Higashi, Taishi</creatorcontrib><creatorcontrib>Arima, Hidetoshi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medicine (ProQuest)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>ProQuest Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content (ProQuest)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of nanomedicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kameyama, Kazuhisa</au><au>Motoyama, Keiichi</au><au>Tanaka, Nao</au><au>Yamashita, Yuki</au><au>Higashi, Taishi</au><au>Arima, Hidetoshi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin</atitle><jtitle>International journal of nanomedicine</jtitle><addtitle>Int J Nanomedicine</addtitle><date>2017-01-01</date><risdate>2017</risdate><volume>12</volume><spage>3433</spage><epage>3446</epage><pages>3433-3446</pages><issn>1178-2013</issn><issn>1176-9114</issn><eissn>1178-2013</eissn><abstract>Mitophagy is the specific autophagic elimination system of mitochondria, which regulates cellular survival via the removal of damaged mitochondria. Recently, we revealed that folate-appended methyl-β-cyclodextrin (FA-M-β-CyD) provides selective antitumor activity in folate receptor-α (FR-α)-expressing cells by the induction of autophagy. In this study, to gain insight into the detailed mechanism of this antitumor activity, we focused on the induction of mitophagy by the treatment of FR-α-expressing tumor cells with FA-M-β-CyD. In contrast to methyl-β-cyclodextrin, FA-M-β-CyD entered KB cells, human epithelial cells from a fatal cervical carcinoma (FR-α (+)) through FR-α-mediated endocytosis. The transmembrane potential of isolated mitochondria after treatment with FA-M-β-CyD was significantly elevated. In addition, FA-M-β-CyD lowered adenosine triphosphate (ATP) production and promoted reactive oxygen species production in KB cells (FR-α (+)). Importantly, FA-M-β-CyD enhanced light chain 3 (LC3) conversion (LC3-I to LC3-II) in KB cells (FR-α (+)) and induced PTEN-induced putative kinase 1 (PINK1) protein expression, which is involved in the induction of mitophagy. Furthermore, FA-M-β-CyD had potent antitumor activity in BALB/c
mice xenografted with KB cells (FR-α (+)) without any significant side effects. Taken together, these findings demonstrate that the autophagic cell death elicited by FA-M-β-CyD could be associated with mitophagy induced by an impaired mitochondrial function.</abstract><cop>New Zealand</cop><pub>Taylor & Francis Ltd</pub><pmid>28496320</pmid><doi>10.2147/IJN.S133482</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1178-2013 |
ispartof | International journal of nanomedicine, 2017-01, Vol.12, p.3433-3446 |
issn | 1178-2013 1176-9114 1178-2013 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_6de3764b95d44cbeb4b1ea0ff8ee86a8 |
source | Publicly Available Content (ProQuest); Taylor & Francis Open Access Journals; PubMed Central |
subjects | Adenosine triphosphate Angiogenesis Animals Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Apoptosis Autophagy Autophagy - drug effects beta-Cyclodextrins - chemistry beta-Cyclodextrins - pharmacology Cancer Cell Survival - drug effects Cervical cancer Clinical trials folate receptor Folate Receptor 1 - metabolism Folic Acid - chemistry Folic Acid - pharmacology Graduate studies Humans KB Cells - drug effects Kinases Life sciences Male methyl--cyclodextrin Mice Mice, Inbred BALB C Mitochondria Mitochondrial Degradation - drug effects mitophagy Molecular Targeted Therapy - methods Original Research Protein Kinases - metabolism Reactive oxygen species tumor targeting Tumors Vitamin B Xenograft Model Antitumor Assays |
title | Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T16%3A20%3A26IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Induction%20of%20mitophagy-mediated%20antitumor%20activity%20with%20folate-appended%20methyl-%CE%B2-cyclodextrin&rft.jtitle=International%20journal%20of%20nanomedicine&rft.au=Kameyama,%20Kazuhisa&rft.date=2017-01-01&rft.volume=12&rft.spage=3433&rft.epage=3446&rft.pages=3433-3446&rft.issn=1178-2013&rft.eissn=1178-2013&rft_id=info:doi/10.2147/IJN.S133482&rft_dat=%3Cproquest_doaj_%3E1899106735%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c475t-a822956b8a21e60de2ce965ff7a221b87e6f382007895ea3efb0cb2f28ee5b123%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2239158591&rft_id=info:pmid/28496320&rfr_iscdi=true |